Veraxa Biotech Holding AG (VRXAW) Operating Leases (2024 - 2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Operating Leases of $1.4 million for Q4 2025, up 76.56% year-over-year from $808291.1 in Q4 2024, and up 76.56% quarter-over-quarter from $808291.1 in Q4 2024.
Veraxa Biotech Holding AG (VRXAW) Operating Leases (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Operating Leases for 2 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases rose 76.56% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 76.56% YoY), while the FY2025 annual figure was $1.4 million, up 76.56% from the prior year.
- Operating Leases grew to $1.4 million in Q4 2025 per VRXAW's latest filing, from $808291.1 in the prior quarter.
- Across five years, Operating Leases topped out at $1.4 million in Q4 2025 and bottomed at $808291.1 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.43 Mn |
| Dec 31, 2024 | 808,291.07 |